These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32842946)

  • 1. In Silico Molecular Interaction Studies of Chitosan Polymer with Aromatase Inhibitor: Leads to Letrozole Nanoparticles for the Treatment of Breast Cancer.
    Mishra K; Verma SK; Ratre P; Banjare L; Jain A; Thareja S; Jain AK
    Anticancer Agents Med Chem; 2021; 21(9):1191-1199. PubMed ID: 32842946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Pharmacophore Study of Triazole Analogues as Aromatase Inhibitors.
    Banjare L
    Anticancer Agents Med Chem; 2024; 24(4):288-303. PubMed ID: 37921212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Docking Studies and Biological Activity of New Benzimidazole- Triazolothiadiazine Derivatives as Aromatase Inhibitor.
    Acar Çevik U; Kaya Çavuşoğlu B; Sağlık BN; Osmaniye D; Levent S; Ilgın S; Özkay Y; Kaplancıklı ZA
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32252458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comprehensive Physicochemical, In Vitro and Molecular Characterization of Letrozole Incorporated Chitosan-Lipid Nanocomplex.
    Azandaryani AH; Kashanian S; Shahlaei M; Derakhshandeh K; Motiei M; Moradi S
    Pharm Res; 2019 Mar; 36(4):62. PubMed ID: 30850895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic combination of antioxidants, silver nanoparticles and chitosan in a nanoparticle based formulation: Characterization and cytotoxic effect on MCF-7 breast cancer cell lines.
    Nayak D; Minz AP; Ashe S; Rauta PR; Kumari M; Chopra P; Nayak B
    J Colloid Interface Sci; 2016 May; 470():142-152. PubMed ID: 26939078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent aromatase inhibitors and molecular mechanism of inhibitory action.
    Kang H; Xiao X; Huang C; Yuan Y; Tang D; Dai X; Zeng X
    Eur J Med Chem; 2018 Jan; 143():426-437. PubMed ID: 29202405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design Graph Theoretical Analysis and
    Kunjiappan S; Panneerselvam T; Somasundaram B; Sankaranarayanan M; Parasuraman P; Joshi SD; Arunachalam S; Murugan I
    Anticancer Agents Med Chem; 2018; 18(13):1900-1918. PubMed ID: 29956638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
    Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
    Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, In vitro and In silico Studies of Novel Bis-triazolopyridopyrimidines from Curcumin Analogues as Potential Aromatase Agents.
    Gomha SM; El-Sayed AAA; Zaki MEA; Alrehaily A; Elbadawy HM; Al-Shahri ABA; Alsenani SR; Abouzied AS
    Chem Biodivers; 2024 Aug; 21(8):e202400701. PubMed ID: 38829745
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Shah U; Patel S; Patel M; Jain N; Pandey N; Chauhan A; Patel A; Patel S
    Anticancer Agents Med Chem; 2022; 22(7):1370-1385. PubMed ID: 34455966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico design of AVP (4-5) peptide and synthesis, characterization and in vitro activity of chitosan nanoparticles.
    Kecel-Gunduz S; Budama-Kilinc Y; Cakir-Koc R; Zorlu T; Bicak B; Kokcu Y; E Ozel A; Akyuz S
    Daru; 2020 Jun; 28(1):139-157. PubMed ID: 31942695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, in vitro and in silico studies of some novel thiazole-dihydrofuran derivatives as aromatase inhibitors.
    Osmaniye D; Görgülü Ş; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
    Bioorg Chem; 2021 Sep; 114():105123. PubMed ID: 34214753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New azolyl-derivatives as multitargeting agents against breast cancer and fungal infections: synthesis, biological evaluation and docking study.
    Maccallini C; Gallorini M; Sisto F; Akdemir A; Ammazzalorso A; De Filippis B; Fantacuzzi M; Giampietro L; Carradori S; Cataldi A; Amoroso R
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1632-1645. PubMed ID: 34289751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of letrozole-loaded poly(d,l-lactide) nanoparticles for drug delivery in breast cancer therapy.
    Alemrayat B; Elhissi A; Younes HM
    Pharm Dev Technol; 2019 Feb; 24(2):235-242. PubMed ID: 29561210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead optimization of COX-2 inhibitor nimesulide analogs to overcome aromatase inhibitor resistance in breast cancer cells.
    Su B; Chen S
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6733-5. PubMed ID: 19854050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, Characterization, and Anticancer Activity Assessment of Chitosan/TPP Nanoparticles Loaded with
    Kancha MM; Mehrabi M; Bitaraf FS; Vahedi H; Alizadeh M; Bernkop-Schnürch A
    Anticancer Agents Med Chem; 2024; 24(7):533-543. PubMed ID: 38243949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferrozoles: Ferrocenyl derivatives of letrozole with dual effects as potent aromatase inhibitors and cytostatic agents.
    Diaz de Greñu B; Fernández-Aroca DM; Organero JA; Durá G; Jalón FA; Sánchez-Prieto R; Ruiz-Hidalgo MJ; Rodríguez AM; Santos L; Albasanz JL; Manzano BR
    J Biol Inorg Chem; 2023 Sep; 28(6):531-547. PubMed ID: 37458856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, docking study and cytotoxic activity evaluation of some novel letrozole analogs.
    Vosooghi M; Firoozpour L; Rodaki A; Pordeli M; Safavi M; Ardestani SK; Dadgar A; Asadipour A; Moshafi MH; Foroumadi A
    Daru; 2014 Dec; 22(1):83. PubMed ID: 25539909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical Characterization of Curcumin Loaded Chitosan Nanoparticles: Implications in Cervical Cancer.
    Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MMA
    Anticancer Agents Med Chem; 2018; 18(8):1131-1137. PubMed ID: 29651963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors.
    Acar Çevik U; Celik I; Işık A; Ahmad I; Patel H; Özkay Y; Kaplancıklı ZA
    J Biomol Struct Dyn; 2023 Mar; 41(5):1944-1958. PubMed ID: 35037830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.